Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

NCT06475235 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Primary Central Nervous System Lymphoma

Interventions

DRUG: Pembrolizumab
DRUG: Methotrexate
DRUG: Temozolomide
DRUG: Rituximab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]